Givaudan's Results Should Provide Some Relief -- Market Talk

Dow Jones

Jan 29

1015 GMT - Givaudan's full-year results should provide some relief from negative sentiment around the sector amid fears of consumer slowdown, Vontobel analyst Arben Hasanaj says in a research note. The Swiss manufacturer of flavors, fragrances and active cosmetic ingredients showed more volatile top-line trends at the end of 2025, but with diversification paying off and some improvement in the last quarter, the analyst says. "We remain constructive on 2026 given Givaudan's differentiated position and abating cost headwinds," Hasanaj says. The company's current valuation is overly negative in light of the company's potential for value creation, he adds. Shares trade 5.9% lower at 2,953 Swiss francs. (nina.kienle@wsj.com)

(END) Dow Jones Newswires

January 29, 2026 05:15 ET (10:15 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2607088644"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2607088644\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2607088644?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-29 18:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2607088644","market":"hk","top_or_hot":-1,"title":"Givaudan's Results Should Provide Some Relief -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1015 GMT - Givaudan's full-year results should provide some relief from negative sentiment around the sector amid fears of consumer slowdown, Vontobel analyst Arben Hasanaj says in a research note. The Swiss manufacturer of flavors, fragrances and active cosmetic ingredients showed more volatile top-line trends at the end of 2025, but with diversification paying off and some improvement in the last quarter, the analyst says. \"We remain constructive on 2026 given Givaudan's differentiated position and abating cost headwinds,\" Hasanaj says. The company's current valuation is overly negative in light of the company's potential for value creation, he adds. Shares trade 5.9% lower at 2,953 Swiss francs. (nina.kienle@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 29, 2026 05:15 ET (10:15 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Givaudan's Results Should Provide Some Relief -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGivaudan's Results Should Provide Some Relief -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-29 18:15</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1015 GMT - Givaudan's full-year results should provide some relief from negative sentiment around the sector amid fears of consumer slowdown, Vontobel analyst Arben Hasanaj says in a research note. The Swiss manufacturer of flavors, fragrances and active cosmetic ingredients showed more volatile top-line trends at the end of 2025, but with diversification paying off and some improvement in the last quarter, the analyst says. \"We remain constructive on 2026 given Givaudan's differentiated position and abating cost headwinds,\" Hasanaj says. The company's current valuation is overly negative in light of the company's potential for value creation, he adds. Shares trade 5.9% lower at 2,953 Swiss francs. (nina.kienle@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 29, 2026 05:15 ET (10:15 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GVDNY","symbol_name":"Givaudan SA","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2607088644","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2607088644","pubTimestamp":1769681700,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1015 GMT - Givaudan's full-year results should provide some relief from negative sentiment around the sector amid fears of consumer slowdown, Vontobel analyst Arben Hasanaj says in a research note. The Swiss manufacturer of flavors, fragrances and active cosmetic ingredients showed more volatile top-line trends at the end of 2025, but with diversification paying off and some improvement in the last quarter, the analyst says. \"We remain constructive on 2026 given Givaudan's differentiated position and abating cost headwinds,\" Hasanaj says. The company's current valuation is overly negative in light of the company's potential for value creation, he adds. Shares trade 5.9% lower at 2,953 Swiss francs. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GVDNY":"Givaudan SA","BK4109":"特种化学制品"},"translate_title":"奇华顿的业绩应该会带来一些缓解——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GVDNY":0.9},"content_text":"1015 GMT - Givaudan's full-year results should provide some relief from negative sentiment around the sector amid fears of consumer slowdown, Vontobel analyst Arben Hasanaj says in a research note. The Swiss manufacturer of flavors, fragrances and active cosmetic ingredients showed more volatile top-line trends at the end of 2025, but with diversification paying off and some improvement in the last quarter, the analyst says. \"We remain constructive on 2026 given Givaudan's differentiated position and abating cost headwinds,\" Hasanaj says. The company's current valuation is overly negative in light of the company's potential for value creation, he adds. Shares trade 5.9% lower at 2,953 Swiss francs. (nina.kienle@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 29, 2026 05:15 ET (10:15 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}